You are here: Home > Human Cell Lines > Hematopoetic Malignancies

Hematopoetic Malignancies

Through a licensing agreement with the Barbara Ann Karmanos Cancer Institute (formerly part of Wayne State University), Asterand provides well characterized human cell lines derived from patients with hematopoetic malignancies. These cell lines, developed by Drs. Ayad Al-Katib and Ramzi Mohammad, will be of interest to researchers seeking a cure for lymphoma, leukemia, pancreatic cancer, and macroglobulinema.
All cell lines are provided in cryovial of ~1x106 cells.
All of the cell lines available from Asterand were developed in conjunction with different academic institutions. As a result of our agreements with these institutions, we offer our cell lines to academic and governmental researchers at prices lower than those available to our commercial customers. If you have any questions about this policy, please please email us at ecommerce@asterand.com.
Sort By:
Page of 1
WSU-AML Acute Myeloid Leukemia Cell Line
US Price: $600.00

WSU-AML Acute Myeloid Leukemia Cell Line

An aggressive human suspension line derived from the peripheral blood of a patient with AML


Characterization: Partial interstitial deletion of the long arm (q) of chromosome 9
WSU-DLCL2 Diffuse Large Cell Lymphoma Cell Line
US Price: $600.00

WSU-DLCL2 Diffuse Large Cell Lymphoma Cell Line

Human mature B-cell line suspension line

Characterization: Negative for EBV nuclear antigen and expresses the multidrug resistance phenotype. Cell line also has t (14; 18) (q32; q21) as well as other chromosomal aberrations.
WSU-FSCCL Follicular Small Cleaved Cell Lymphoma Cell Line
US Price: $600.00

WSU-FSCCL Follicular Small Cleaved Cell Lymphoma Cell Line

Human B-cell line

Characterization:
Suspension line an EBV-negative, lymphoma in leukemic phase
WSU-pre-B-ALL Pre-B Acute Lymphoblastic Leukemia Cell Line
US Price: $600.00

WSU-pre-B-ALL Pre-B Acute Lymphoblastic Leukemia Cell Line

Human suspension line established from the peripheral blood of a patient with ALL in leukemic phase

Characterization:
EBV negative; t (1; 19) chromosomal translocation, partial deletion of the short arm (p) of chromosome 9 and a loss of chromosome 13 as clonal abnormalities
WSU-WM Waldenstrom's Macroglobulinemia Cell Line
US Price: $600.00

WSU-WM Waldenstrom's Macroglobulinemia Cell Line

Human B-cell suspension line